Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes
Publication date: | 2020 |
Publisher version: | http://dx.doi.org/10.1182/blood.2020005289 |
Citación: | Blood, 136(12), p. 1419-1432 (2020); doi:10.1182/blood.2020005289 |
Descripción física: | p. 1419-1432 |
Patrocinado por: |
Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (PI17/01061 to S.B.); National Institutes of Health, National Cancer Institute “Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma” (P01CA229100 to E.C.); Ministerio de Ciencia e Innovación (RTI2018-094274-B-I00 to E.C., SAF2017-87811-R to X.S.P., and SAF2017-86126-R to J.I.M.-S.); Generalitat de Catalunya Suport Grups de Recerca AGAUR (2017-SGR-1142 to E.C., and AGAUR 2017-SGR-736 to J.I.M.-S.); German Ministry of Science and Education in the framework of the ICGC MMML-Seq (01KU1002) and ICGC DE-Mining (01KU1505) to R.S. F.N. is supported by a predoctoral fellowship of the Ministerio de Ciencia e Innovación (BES-2016-076372). A.D.-N. is supported by the Department of Education of the Basque Government (PRE_2017_1_0100). |
Id. Proyecto: |
ISCIII/PI17/01061 P01CA229100 MICINN/RTI2018-094274-B-I00 |
Collections
- Artículos [28671]
